Author:
Yoshida Kotaro,Kawashima Hiroko,Kannon Takayuki,Tajima Atsushi,Ohno Naoki,Terada Kanako,Takamatsu Atsushi,Adachi Hayato,Ohno Masako,Miyati Tosiaki,Ishikawa Satoko,Ikeda Hiroko,Gabata Toshifumi
Subject
Radiology, Nuclear Medicine and imaging,Biomedical Engineering,Biophysics
Reference31 articles.
1. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline;Korde;J Clin Oncol,2021
2. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Cardoso;Ann Oncol,2019
3. The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): a review of 20,000 breast cancer patients in the national cancer data base (NCDB);Fayanju;Ann Surg,2018
4. Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers;Ortmann;J Cancer Res Clin Oncol,2022
5. Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers;Tan;Cancer Manag Res,2018